Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$37.58 - $52.57 $187 - $262
-5 Reduced 0.23%
2,152 $87,000
Q4 2022

Feb 06, 2023

BUY
$49.7 - $57.71 $99 - $115
2 Added 0.09%
2,157 $109,000
Q3 2022

Nov 08, 2022

BUY
$53.86 - $66.8 $592 - $734
11 Added 0.51%
2,155 $116,000
Q2 2022

Jul 19, 2022

SELL
$63.83 - $80.0 $5,872 - $7,360
-92 Reduced 4.11%
2,144 $138,000
Q1 2022

Apr 29, 2022

SELL
$76.85 - $89.45 $3,227 - $3,756
-42 Reduced 1.84%
2,236 $173,000
Q4 2021

Jan 24, 2022

SELL
$74.57 - $87.19 $32,661 - $38,189
-438 Reduced 16.13%
2,278 $196,000
Q3 2021

Oct 29, 2021

BUY
$73.77 - $83.61 $3,172 - $3,595
43 Added 1.61%
2,716 $218,000
Q2 2021

Aug 02, 2021

BUY
$80.5 - $88.01 $966 - $1,056
12 Added 0.45%
2,673 $215,000
Q1 2021

Apr 29, 2021

BUY
$76.38 - $86.03 $4,430 - $4,989
58 Added 2.23%
2,661 $224,000
Q4 2020

Jan 21, 2021

SELL
$75.39 - $82.36 $3,467 - $3,788
-46 Reduced 1.74%
2,603 $209,000
Q2 2020

Jul 20, 2020

SELL
$78.66 - $94.14 $3,854 - $4,612
-49 Reduced 1.82%
2,649 $228,000
Q1 2020

Apr 14, 2020

SELL
$71.57 - $93.3 $143 - $186
-2 Reduced 0.07%
2,698 $219,000
Q4 2019

Jan 27, 2020

BUY
$76.7 - $88.45 $34,208 - $39,448
446 Added 19.79%
2,700 $226,000
Q3 2019

Oct 17, 2019

BUY
$81.4 - $89.78 $3,418 - $3,770
42 Added 1.9%
2,254 $197,000
Q2 2019

Jul 23, 2019

SELL
$73.44 - $82.41 $293 - $329
-4 Reduced 0.18%
2,212 $181,000
Q1 2019

Apr 11, 2019

SELL
$64.48 - $81.31 $15,475 - $19,514
-240 Reduced 9.77%
2,216 $180,000
Q4 2018

Jan 17, 2019

BUY
$61.45 - $77.8 $368 - $466
6 Added 0.24%
2,456 $162,000
Q1 2018

Apr 30, 2018

SELL
$62.56 - $72.26 $15,640 - $18,065
-250 Reduced 9.26%
2,450 $159,000
Q2 2017

Aug 10, 2017

BUY
N/A
2,700
2,700 $163,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.3B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.